Atul Pande serves as Executive at Axovant Gene Therapies Ltd., where they oversee executive responsibilities. Since joining the company, Atul Pande has executed 59 insider transactions totaling $8.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 2, 2024 involved receiving (via award) 11,255 shares valued at $0.
Atul Pande currently holds 94,413 shares of Axovant Gene Therapies Ltd. (AXGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Atul Pande has been a net seller of AXGT stock. They have purchased $210.0K and sold $8.0M worth of shares.
Atul Pande's most recent insider trade was on Apr 2, 2024, when they sold 11,255 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $330.00 |
| Discretionary |
| Dec 1, 2023 | IMVT | $196.1K | Sale | 4,847 | $40.46 | Planned |
| Dec 1, 2023 | IMVT | $134.4K | Sale | 3,374 | $39.82 | Planned |
| Dec 1, 2023 | IMVT | $160.2K | Sale | 4,129 | $38.80 | Planned |
| Jun 20, 2023 | KRTX | $0 | Award | 990 | $N/A | Discretionary |
| Apr 12, 2023 | IMVT | $0 | Award | 12,523 | $N/A | Discretionary |
| Sep 30, 2022 | IMVT | $84.0K | Purchase | 15,000 | $5.60 | Discretionary |
| Aug 17, 2022 | IMVT | $0 | Award | 21,059 | $N/A | Discretionary |
| Feb 1, 2022 | KRTX | $277.0K | Sale | 2,500 | $110.80 | Discretionary |
| Feb 1, 2022 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Jan 10, 2022 | IMVT | $0 | Award | 21,726 | $N/A | Discretionary |
| Jan 3, 2022 | KRTX | $326.1K | Sale | 2,500 | $130.44 | Discretionary |
| Jan 3, 2022 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Dec 1, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Dec 1, 2021 | KRTX | $319.3K | Sale | 2,500 | $127.73 | Discretionary |
| Nov 1, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Nov 1, 2021 | KRTX | $341.7K | Sale | 2,500 | $136.67 | Discretionary |
| Oct 1, 2021 | KRTX | $301.8K | Sale | 2,500 | $120.72 | Discretionary |
| Oct 1, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Sep 1, 2021 | KRTX | $294.6K | Sale | 2,500 | $117.82 | Discretionary |
| Sep 1, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Aug 13, 2021 | IMVT | $39.9K | Purchase | 5,000 | $7.98 | Discretionary |
| Aug 2, 2021 | KRTX | $285.4K | Sale | 2,500 | $114.17 | Discretionary |
| Aug 2, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Jul 1, 2021 | KRTX | $281.6K | Sale | 2,500 | $112.66 | Discretionary |
| Jul 1, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| Jun 1, 2021 | KRTX | $278.6K | Sale | 2,500 | $111.44 | Discretionary |
| Jun 1, 2021 | KRTX | $40.0K | Option Exercise | 2,500 | $16.00 | Discretionary |
| May 3, 2021 | KRTX | $276.5K | Sale | 2,500 | $110.61 | Discretionary |